Zacks Small Cap Research on MSN10h
V.MDCX: Medicus Pharma Randomizes First Patient in SKNJCT-003 Phase 2 clinical trial for the treatment of nodular BCC (Basal Cell Carcinoma).MDCX READ THE FULL V.MDCX RESEARCH REPORT First Patient Randomized for Medicus Pharma’s Phase 2 Clinical Study (SKNJCT-003) ...
University of California San Diego is conducting new, Phase 2/3 national epilepsy clinical research trials, called Rise, to ...
Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.
Besides stomach cancer, the FDA also raised a similar concern for PD-1 drugs in first-line esophageal squamous cell carcinoma ...
AI-assisted pathology will enable early, accurate diagnosis of liver disease and offer insights that predict which patients ...
Anyone with any experience as an investor knows that while penny stocks can produce strong returns, they’re also risky. You ...
Investigational immunotherapy candidate, VTP-1000, seeks to address significant unmet need in people with celiac disease.An estimated one in 100 ...
In the ongoing phase 1 study, GIM-407 will be administered orally to healthy volunteers to further characterize the safety, tolerability, and pharmacokinetics. Data collected from this study will help ...
Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.
A team of researchers from City of Hope and The University of Texas M.D. Anderson Cancer Center has reported safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback